Varenicline for e-cigarette cessation
- Sponsor:
- National Cancer Institute
- Sponsor Study ID:
- R01CA296186
- CTO #:
- 104207
- NCT Number:
- NCT07040566
- Phase:
- II
- Protocol Type:
- Health Services Research
- Age Group:
- Adults
- Disease Sites:
- Study Objectives:
- The primary objective is to test the efficacy of varenicline vs. placebo for e-cigarette cessation in adults who report current e-cigarette use. Secondary objectives include examining predictors of e-cigarette cessation and potential moderators of varenicline response and exploring the effects of cessation on cancer-related health biomarkers.
- eConsent:
- Not available
- Study Documents:
-
Open Study Documents
(MUSC NetID required for document access)
For more information about this trial please contact the study team:
-
Medical University of South Carolina
- Principal Investigator, Toll, Benjamin, at toll@musc.edu .
- Study Coordinator, Christian, Rachel, at chrisrac@musc.edu .
Trial opened at the following institutions:
Medical University of South Carolina